» Authors » Leonard P Freedman

Leonard P Freedman

Explore the profile of Leonard P Freedman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 49
Citations 1831
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kahn R, Virk H, Laflamme C, Houston D, Polinski N, Meijers R, et al.
Elife . 2024 Aug; 13. PMID: 39140332
Antibodies are used in many areas of biomedical and clinical research, but many of these antibodies have not been adequately characterized, which casts doubt on the results reported in many...
2.
LaBaer J, Miceli 3rd J, Freedman L
Nat Methods . 2018 Apr; 15(5):303-304. PMID: 29702632
No abstract available.
3.
Freedman L, Venugopalan G, Wisman R
F1000Res . 2017 Jun; 6:604. PMID: 28620458
The preclinical research process is a cycle of idea generation, experimentation, and reporting of results. The biomedical research community relies on the reproducibility of published discoveries to create new lines...
4.
Aittokallio T, Scherer A, Poutanen M, Freedman L
Sci Transl Med . 2017 May; 9(389). PMID: 28490671
A more stratified preclinical design strategy will increase the statistical power and reproducibility of animal studies and their translatability.
5.
Freedman L
Science . 2017 Apr; 356(6333):34. PMID: 28385975
No abstract available.
6.
Freedman L, Gibson M, Bradbury A, Buchberg A, Davis D, Dolled-Filhart M, et al.
Biotechniques . 2016 Jul; 61(1):16-8. PMID: 27401669
Address correspondence to Leonard P. Freedman, Global Biological Standards Institute, 1020 19th Street, NW, Suite 550, Washington, DC, 20036. E-mail: lfreedman@gbsi.org.
7.
Freedman L, Gibson M, Wisman R, Ethier S, Soule H, Reid Y, et al.
Biotechniques . 2015 Oct; 59(4):189-90, 192. PMID: 26458546
No abstract available.
8.
Freedman L
Sci Transl Med . 2015 Jul; 7(294):294ed7. PMID: 26136474
No abstract available.
9.
Freedman L, Cockburn I, Simcoe T
PLoS Biol . 2015 Jun; 13(6):e1002165. PMID: 26057340
Low reproducibility rates within life science research undermine cumulative knowledge production and contribute to both delays and costs of therapeutic drug development. An analysis of past studies indicates that the...
10.
Freedman L, Gibson M, Ethier S, Soule H, Neve R, Reid Y
Nat Methods . 2015 May; 12(6):493-7. PMID: 26020501
No abstract available.